TCI Wealth Advisors, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 181 filers reported holding HAEMONETICS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2023$17,378
+5.2%
2100.0%0.00%0.0%
Q4 2022$16,516
+3.2%
2100.0%0.00%
-33.3%
Q3 2022$16,000
+23.1%
210
+1.4%
0.00%
+50.0%
Q2 2022$13,0000.0%2070.0%0.00%0.0%
Q1 2022$13,000
+1200.0%
207
+935.0%
0.00%
Q4 2021$1,000
-88.9%
20
-84.8%
0.00%
-100.0%
Q3 2021$9,000
-10.0%
132
-8.3%
0.00%
-50.0%
Q2 2021$10,000
+400.0%
144
+620.0%
0.00%
+100.0%
Q1 2021$2,0000.0%200.0%0.00%0.0%
Q4 2020$2,0000.0%200.0%0.00%0.0%
Q3 2020$2,0000.0%200.0%0.00%0.0%
Q2 2020$2,0000.0%200.0%0.00%0.0%
Q1 2020$2,0000.0%200.0%0.00%0.0%
Q4 2019$2,000
-33.3%
200.0%0.00%0.0%
Q3 2019$3,000
+50.0%
200.0%0.00%0.0%
Q2 2019$2,0000.0%200.0%0.00%0.0%
Q1 2019$2,0000.0%200.0%0.00%0.0%
Q4 2018$2,000
-33.3%
20
-28.6%
0.00%0.0%
Q3 2018$3,000
-25.0%
28
-36.4%
0.00%
-50.0%
Q2 2018$4,000
+300.0%
44
+120.0%
0.00%
Q1 2018$1,0000.0%200.0%0.00%
Q4 2017$1,0000.0%200.0%0.00%
Q3 2017$1,0000.0%200.0%0.00%
-100.0%
Q2 2017$1,0000.0%200.0%0.00%0.0%
Q1 2017$1,0000.0%200.0%0.00%0.0%
Q4 2016$1,0000.0%200.0%0.00%0.0%
Q3 2016$1,0000.0%200.0%0.00%0.0%
Q2 2016$1,000200.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders